Director George H. Lowell resigns from BiondVax board, stays on Scientific Advisory Board

Scinai Immunotherapeutics Ltd.

Resignation from Board effective May 12, 2023; served since 2008.
Resignation not due to any disagreement with the Company's operations, policies, or practices.
Will remain on Scientific Advisory Board and serve as liaison between Advisory Board and Board.
Compensation for continuing role and liaison duties currently under discussion.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

George H. Lowell

Director

SCNI · Scinai Immunotherapeutics Ltd.

Effective: 2023-05-12
Filed: May 11, 2023, 7:59 PM ET

On May 10, 2023, Mr. George H. Lowell submitted to the board of directors (the “Board”) of BiondVax Pharmaceuticals Ltd. (the “Company”) his resignation from his position as a member of the Board, effective May 12, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

George H. Lowell resigned as Director at Scinai Immunotherapeutics Ltd..

Action: resigned
Role: Director

Exact text from the filing

On May 10, 2023, Mr. George H. Lowell submitted to the board of directors (the “Board”) of BiondVax Pharmaceuticals Ltd. (the “Company”) his resignation from his position as a member of the Board, effective May 12, 2023.

View on SEC.gov

Scinai Immunotherapeutics Ltd. filing history →

Source: SEC EDGAR

accession 0001213900-23-038612

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.